Satapathy Prakasini, Shamim Muhammad Aaqib, Padhi Bijaya K, Gandhi Aravind P, Sandeep Mokanpally, Suvvari Tarun Kumar, Kumar Jogender, Kaur Gunjeet, Barboza Joshuan J, Schlagenhauf Patricia, Sah Ranjit
Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
Medical Laboratories Techniques Department, AL-Mustaqbal University, Hillah, Babil, Iraq.
Commun Med (Lond). 2024 Sep 30;4(1):188. doi: 10.1038/s43856-024-00595-8.
Although the recent literature indicates that mpox (monkeypox) primarily affects men, there are also multiple reports in women. Estimates of the sex distribution of mpox patients and patterns will enable a better understanding of the ongoing mpox outbreak.
In this systematic review and meta-analysis, seven databases were searched for studies published in English up to January 4, 2023. The proportion of women with mpox was the primary outcome. A random-effects model was fitted for the primary outcome, and a sensitivity analysis was performed to check possible outliers in the studies.
Here we screened 470 articles and included 60 studies for qualitative synthesis. 42 studies with 3125 women out of 47,407 confirmed cases were found suitable for meta-analysis. The pooled proportion of female patients is 17.22% (95% CI: 10.49-25.11; I = 98.86%). Subgroup analyses reveal higher proportion before 2022 [44.09% (42.93-46.86] than 2022 onwards [2.40% (1.17-3.98)], and in endemic countries [43.13% (37.63-48.72)] than in nonendemic countries [6.15% (2.20-11.65)].
There is considerable caseload (17.22%) amongst women, which must be seen in the context of a much higher proportion (44.09%) in studies prior to 2022 compared to 2.40% in the 2022 outbreak indicating an epidemiological shift. Data on disease characteristics among women with mpox disease are scarce. Further studies should focus on these aspects to better understand the disease in women and empower epidemiologists and clinicians to make evidence-based decisions for this vulnerable group.
尽管近期文献表明猴痘主要影响男性,但也有关于女性感染猴痘的多份报告。对猴痘患者的性别分布及模式进行评估,将有助于更好地了解当前的猴痘疫情。
在这项系统评价和荟萃分析中,检索了七个数据库,查找截至2023年1月4日以英文发表的研究。女性猴痘患者的比例为主要结局指标。对主要结局指标采用随机效应模型,并进行敏感性分析以检查研究中可能存在的异常值。
在此我们筛选了470篇文章,纳入60项研究进行定性综合分析。发现42项研究(共47407例确诊病例,其中3125例为女性)适合进行荟萃分析。女性患者的合并比例为17.22%(95%置信区间:10.49 - 25.11;I² = 98.86%)。亚组分析显示,2022年之前女性患者比例[44.09%(42.93 - 46.86)]高于2022年及之后[2.40%(1.17 - 3.98)],在流行国家[43.13%(37.63 - 48.72)]高于非流行国家[6.15%(2.20 - 11.65)]。
女性猴痘病例数相当可观(17.22%),与2022年疫情期间2.40%的比例相比,2022年之前的研究中女性比例要高得多(44.09%),这表明了一种流行病学转变。关于女性猴痘患者疾病特征的数据稀缺。进一步的研究应聚焦于这些方面,以更好地了解女性患者的病情,并使流行病学家和临床医生能够为这一弱势群体做出基于证据的决策。